VAIRAVAN LATHA (SVP Chief Financial Officer) sold 3.1% of their position (2.85K shares) of ARCUTIS BIOTHERAPEUTICS, INC. on the open market
Open‑market sale worth $71.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/3/2026ACC: 0001628280-26-014325
Officer· SVP Chief Financial Officer
Since Feb 2026
+94.15K
Net shares
Net buyer
$71.8K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
97K acquired · 2.85K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+27K
Price / share
—
Trade value
—
% of position
42.4%
2/27/2026
63.61K→90.61K
Common Stock
Direct
Shares
−2.77K
Price / share
$25.16
Trade value
$69.74K
% of position
3.1%
3/2/2026
90.61K→87.83K
Common Stock
Direct
Shares
−81.00
Price / share
$25.91
Trade value
$2.10K
% of position
0.1%
3/2/2026
87.83K→87.75K
Total
Net shares
+24.15K
Net value
-$71.84K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/27/2026 | A · Award | +27K | — | — | 42.4% | 63.61K | 90.61K |
| Common Stock Direct | 3/2/2026 | S · Sale | −2.77K | $25.16 | $69.74K | 3.1% | 90.61K | 87.83K |
| Common Stock Direct | 3/2/2026 | S · Sale | −81.00 | $25.91 | $2.10K | 0.1% | 87.83K | 87.75K |
| Total | +24.15K | -$71.84K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
70K shares
Shares
+70K
Strike price
26.97
Held after
70K
Exercisable
—
2/27/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock70K shares | 2/27/2026 | A · Award | +70K | 26.97 | — | 70K |